Myriad Genetics

SALT LAKE CITY, UT · Biotech · Public

Genetic testing panels for hereditary cancer, prenatal, oncology, and mental health risk assessment

New patent · Oct 20

Claim this profile

Follows are private to you and power your alerts

Updated Oct 23, 2026 · myriad.com

Sector: Biotech
Headquarters: SALT LAKE CITY, UT
Latest Form D: Nov 2017
Total capital: $25M

Federal grants: None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
Private capital raised: None on recordNo Form D filings on SEC EDGAR. Some raises are not filed.
Federal contracts: $25M; 115 awards · Health and Human S, Justice, Veterans Affairs; Rank in Biotech#35 of 4373
Granted patents: 18; 22 pending · first 2021; Rank in peer group#53 of 1449

Capital timeline

Latest events

Oct 2024Federal contractVeterans Affairs · Prolaris Testing$17K
Oct 2023Federal contractVeterans Affairs · Prolaris Testing$155K
Sep 2022Federal contractVeterans Affairs · Prolaris Testing$132K
Mar 2022Federal contractVeterans Affairs · Cancer Testing$4K
Dec 2020Federal contractVeterans Affairs · Prolaris Test Results For Biopsies Sent To Lab$6K
Sep 2020Federal contractDefense · Myraid Genetic Testing$50K
Dec 2019Federal contractVeterans Affairs · Prolaris Test Results For Biopsies Sent To Lab$27K

Show 106 earlier federal awards

Jul 2019Federal contractDefense · Myriad Genetics Testing$100K
Dec 2018Federal contractVeterans Affairs · Prolaris Test Results For Biopsies Sent To Lab$27K
Jul 2018Federal contractDefense · Myriad Genetic Testing$100K
Dec 2017Federal contractVeterans Affairs · Prolaris Test Results For Biopsies Sent To Lab$3K
Jun 2017Federal contractDefense · Igf::ot::igf Myriad Genetic Testing$100K
Dec 2016Federal contractVeterans Affairs · Prolaris Test Results For Biopsies Sent To Lab$24K
Mar 2014Federal contractDefense · Myriad Genetic Testing$150K
Sep 2013Federal contractVeterans Affairs · Igf::ot::igf - Specialized Testing (brac 1&BRAC 2 Analysis$4K
Sep 2013Federal contractDefense · Igf::ot::igf Lab Mail Out For Tests$54K
May 2013Federal contractVeterans Affairs · BRAC1 And BRAC2 Genetic Test For Breast And Ovarian Cancer.$27K
Apr 2013Federal contractVeterans Affairs · Igf::ot::igf Brac Testing This Is A 1 Yr 10000.00 10000.00 Serverable Contract That Will Start March 1, 2013 To February 28, 2014$10K
Feb 2013Federal contractDefense · Lot - Myriad Genetic Testing$150K
Feb 2013Federal contractDefense · 1 Lot-myriad Genetic Testing Call Order$10K
Dec 2012Federal contractVeterans Affairs · Igf::ot::igf$20K
Oct 2012Federal contractDefense · Lab Mailouts For Tests$81K
Oct 2012Federal contractDefense · Genetic Laboratory Testing$257K
Oct 2012Federal contractVeterans Affairs · Igf::ot::igf - Lab Testing - Comprehensive$33K
Aug 2012Federal contractDefense · Comprehensive Brac Analysis$70K
Jun 2012Federal contractDefense · Bracanalysis$3K
May 2012Federal contractDefense · Testing, Brac Analysis, Genetic$3K
May 2012Federal contractDefense · Brac Analysis$3K
Feb 2012Federal contractVeterans Affairs · Referral Lab For Brac Analysis$14K
Feb 2012Federal contractDefense · Comprehensive Brca Analysis$139K
Dec 2011Federal contractVeterans Affairs · Braca Analysis$3K
Nov 2011Federal contractVeterans Affairs · Laboratory Test$10K
Oct 2011Federal contractVeterans Affairs · Brac Analysis$20K
Oct 2011Federal contractDefense · Laboratory Mailouts For Tests$76K
Oct 2011Federal contractDefense · Genetic Laboratory Testing$219K
Oct 2011Federal contractVeterans Affairs · Fee Basis Testing$13K
Sep 2011Federal contractVeterans Affairs · Comprehensive Brac Analysis$3K
Jul 2011Federal contractVeterans Affairs · Brca Analysis, Laboratory Testing$3K
Jun 2011Federal contractVeterans Affairs · Comprehensive BRAC1 And BRAC2 Gene Analysis For Possible Cancer$3K
Apr 2011Federal contractVeterans Affairs · Dna Testing$3K
Feb 2011Federal contractVeterans Affairs · Brca Cancer Test For Va Patient$7K
Dec 2010Federal contractDefense · Myriad Lab Tests ML4 CC99$21K
Dec 2010Federal contractDefense · Comprehensive Brac Analysis$90K
Dec 2010Federal contractVeterans Affairs · 674C10194 For Laboratory Testing Requirement For Path&lab Med Svc (113)$3K
Nov 2010Federal contractVeterans Affairs · Brac Test$3K
Oct 2010Federal contractVeterans Affairs · Brac Test$3K
Oct 2010Federal contractDefense · Genetic Laboratory Testing$136K
Oct 2010Federal contractDefense · Myriad Lab Tests ML4 CC98$9K
Oct 2010Federal contractVeterans Affairs · TAS::36 0160::TAS Medical Services$17K
Oct 2010Federal contractVeterans Affairs · Lab Testing Of Brac Analysis For Vamc Memphis, Tn$16K
Sep 2010Federal contractDefense · Laboratory Mailouts For Tests$44K
Sep 2010Federal contractVeterans Affairs · Breast Cancer Lab$6K
Aug 2010Federal contractVeterans Affairs · TAS::36 0160::TAS Medical Services$4K
Aug 2010Federal contractDefense · Myriad Lab Tests ML4 CC97$19K
Jul 2010Federal contractVeterans Affairs · Medical Service & Supplies$3K
Jul 2010Federal contractDefense · Myriad Lab Tests ML4 CC96$16K
Jun 2010Federal contractVeterans Affairs · Laboratory Testing$3K
Jun 2010Federal contractDefense · Myriad Lab Tests ML4 CC94$19K
Jun 2010Federal contractDefense · Myriad Lab Tests ML4 CC95$13K
May 2010Federal contractVeterans Affairs · Brac Analysis Myraid Genetics$17K
May 2010Federal contractVeterans Affairs · TAS::36 0160::TAS Medical Services$17K
May 2010Federal contractVeterans Affairs · Lab Test$3K
May 2010Federal contractVeterans Affairs · Refence Lab Used By Pathology & Laboratory Medicine Service.$3K
Apr 2010Federal contractDefense · Myriad Lab Tests ML4 CC93$9K
Mar 2010Federal contractDefense · Myriad Lab Tests ML4 CC92$23K
Mar 2010Federal contractDefense · Myriad Lab Tests ML4 CC90$16K
Mar 2010Federal contractDefense · Myriad Lab Tests ML4 CC91$17K
Jan 2010Federal contractVeterans Affairs · Special Genetic Testing$3K
Dec 2009Federal contractVeterans Affairs · Laboratory Testing Services$18K
Dec 2009Federal contractDefense · Myriad Lab Tests ML4 CC89$20K
Dec 2009Federal contractDefense · Myriad Lab Tests ML4 CC88$15K
Dec 2009Federal contractVeterans Affairs · Medical Services$3K
Nov 2009Federal contractVeterans Affairs · Medical Services$3K
Nov 2009Federal contractVeterans Affairs · Surgical Instruments$44K
Oct 2009Federal contractDefense · Myriad Genetics Lab Tests ML4 CC86$10K
Oct 2009Federal contractDefense · Myriad Genetics Lab Testing ML4 CC87$18K
Oct 2009Federal contractDefense · Myriad Lab Tests ML4 CC84$14K
Oct 2009Federal contractDefense · S3820 Comprehensive Brac Analysis$99K
Oct 2009Federal contractDefense · Myriad Genetics Lab Testing ML4 CC85$6K
Oct 2009Federal contractDefense · Laboratory Mailouts For Tests$34K
Oct 2009Federal contractVeterans Affairs · Comprehensive Brac Analysis Full Sequence And Large Arrange Analysis. Genetic Testing For Hereditary Breast Cancer.$19K
Oct 2009Federal contractVeterans Affairs · Professional, Admin, And Management Support Svc$3K
Sep 2009Federal contractVeterans Affairs · Brac Comprehensive Abalysis$3K
Aug 2009Federal contractVeterans Affairs · Medical Services$3K
Jul 2009Federal contractVeterans Affairs · Miscellaneous$4K
Jul 2009Federal contractVeterans Affairs · Small Purchase Data$3K
Jul 2009Federal contractVeterans Affairs · Small Purchase Data$3K
Jun 2009Federal contractVeterans Affairs · Medical Services$3K
Mar 2009Federal contractVeterans Affairs · Small Purchase Data$3K
Feb 2009Federal contractDefense · Genetic Breast Cancer Screening Ffp$82K
Feb 2009Federal contractDefense · Comprehensive Bracanalysis Services$167K
Feb 2009Federal contractVeterans Affairs · Small Purchase Data$25K
Jan 2009Federal contractDefense · Medical Laboratory Testing$3K
Oct 2008Federal contractVeterans Affairs · Laboratory Testing$3K
Oct 2008Federal contractVeterans Affairs · Brac Analyisis Molecular Testing$3K
Sep 2008Federal contractDefense · Laboratory Mailouts$14K
Jun 2008Federal contractVeterans Affairs · Colaris Test$3K
Apr 2008Federal contractVeterans Affairs · Brca Analysis: Brca 1 Brca 2$3K
Mar 2008Federal contractDefense · Brac Analysis Testing$3K
Jan 2008Federal contractDefense · Laboratory Mailouts For Tests$76K
Dec 2007Federal contractDefense · Genetic Breast Cancer Sceening$97K
Oct 2007Federal contractVeterans Affairs · Brac Analysis:$3K
Sep 2005Federal contractHealth and Human S · Analysis Of Yeast Two-hybrid Proteins$541K
Sep 2004Federal contractJustice · Dna Test For La$1M
Aug 2004Federal contractJustice · Dna Test For Alaska$280K
Aug 2004Federal contractJustice · Dna Test For Mt$163K
Aug 2004Federal contractJustice · Dna Test For Ms$673K
Jul 2004Federal contractJustice · Dna Order For Puerto Rico Under Bpa 2003BF021$282K
Jun 2004Federal contractHealth and Human S · Identifying Targets For Therapeutics Using Proteomics Technology$12.8M
May 2004Federal contractJustice · Dna Tests For Oregon$818K
Apr 2004Federal contractJustice · Dna Testing For Sc$466K
Mar 2004Federal contractJustice · Dna Testing For Oh$1.2M
Sep 2003Federal contractHealth and Human S$3.1M

Federal awards are summed by year (113 awards); hover a bar for the split. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

3 records have no date or no amount, so they aren’t placed on the timeline.

Standing among 1449 peers

Line = median

Biotech · Molecule

Granted patents#53 · top 4%

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

From SEC Form D filings

Alexander C. FordExecutive OfficerNamed in SEC Form D filings
Bernard F. TobinExecutive OfficerNamed in SEC Form D filings
Dennis C. LangerDirectorNamed in SEC Form D filings
Gary A. KingExecutive OfficerNamed in SEC Form D filings
Helner Bryan DreismannDirectorNamed in SEC Form D filings
Jerry S. LanchburyExecutive OfficerNamed in SEC Form D filings

Show all 16 people

John T. HendersonDirectorNamed in SEC Form D filings
Lawrence C. BestDirectorNamed in SEC Form D filings
Mark C. CaponeExecutive Officer, DirectorNamed in SEC Form D filings
Mark F. VerrattiExecutive OfficerNamed in SEC Form D filings
Ralph L. McDadeExecutive OfficerNamed in SEC Form D filings
Richard S. MarshExecutive OfficerNamed in SEC Form D filings
Richard Bryan RiggsbeeExecutive OfficerNamed in SEC Form D filings
S. Louise PhanstielDirectorNamed in SEC Form D filings
Walter C. GilbertDirectorNamed in SEC Form D filings
W. Lloyd SandersExecutive OfficerNamed in SEC Form D filings

What it has protected

USPTO · 18 granted of 40

Oct 20, 2026New patentCancer BiomarkersUSPTOUS 12,767,988
Jul 21, 2026GrantedArtificial Intelligence Predictive Interactivity Based On Recursive Data AnalysisUSPTOUS 12,688,912
Jul 16, 2026PendingDetecting Cancer RiskUSPTOApplication 19565908

Show all 40 patent records

Cancer BiomarkersOct 20, 2026 · US 12,767,988Granted
Artificial Intelligence Predictive Interactivity Based On Recursive Data AnalysisJul 21, 2026 · US 12,688,912Granted
Detecting Cancer RiskJul 16, 2026 · Application 19565908Pending
Cancer BiomarkersJul 14, 2026 · US 12,680,139Granted
Methods And Materials For Assessing Loss Of HeterozygosityJul 7, 2026 · US 12,674,207Granted
Hereditary Cancer GenesJun 25, 2026 · Application 19282486Pending
Detecting Cancer RiskMay 26, 2026 · US 12,637,716Granted
Methods And Materials For Assessing Loss Of HeterozygosityApr 7, 2026 · US 12,595,513Granted
Detecting Cancer RiskMar 17, 2026 · US 12,577,622Granted
Signatures For Predicting Cancer Immune Therapy ResponseMar 5, 2026 · Application 19245180Pending
Methods And Materials For Assessing Homologous Recombination DeficiencySep 23, 2025 · US 12,421,555Granted
Hereditary Cancer GenesSep 9, 2025 · US 12,410,478Granted
Methods And Materials For Assessing Loss Of HeterozygosityAug 7, 2025 · Application 19088442Pending
Methods And Materials For Assessing Homologous Recombination DeficiencyJul 10, 2025 · Application 19088496Pending
Methods And Materials For Assessing Loss Of HeterozygosityJul 3, 2025 · Application 19087361Pending
Methods And Materials For Assessing Homologous Recombination DeficiencyJun 5, 2025 · Application 19048611Pending
Methods And Materials For Assessing Homologous Recombination DeficiencyFeb 11, 2025 · US 12,221,656Granted
Method Of Using Biomarkers And Clinical Variables For Predicting Chemotherapy BenefitDec 31, 2024 · US 12,180,551Granted
Artificial Intelligence Predictive Interactivity Based On Recursive Data AnalysisNov 7, 2024 · Application 18690243Pending
Global Polygenic Risk Assessment For Breast CancerSep 12, 2024 · Application 18277554Pending
Electronic Variant ClassificationAug 22, 2024 · Application 18646644Pending
Cancer BiomarkersJun 6, 2024 · Application 18442036Pending
Polygenic Trait Prediction Using Local AncestryAug 17, 2023 · Application 17920013Pending
Methods And Materials For Assessing Homologous Recombination Deficiency In Breast Cancer SubtypesJul 6, 2023 · Application 18076279Pending
Comprehensive Polygenic Risk Prediction For Breast CancerJun 1, 2023 · Application 17920012Pending
Signatures For Predicting Cancer Immune Therapy ResponseMar 30, 2023 · Application 18072520Pending
Method Of Using Biomarkers And Clinical Variables For Predicting Chemotherapy BenefitNov 22, 2022 · US 11,505,832Granted
Gene Signatures For Cancer PrognosisAug 18, 2022 · Application 17678357Pending
Methods Of Detecting CancerAug 4, 2022 · Application 17575301Pending
Methods And Materials For Assessing Loss Of HeterozygosityJun 30, 2022 · Application 17499284Pending
Methods And Materials For Assessing Allelic ImbalanceJun 30, 2022 · Application 17545611Pending
Gene Signatures For Cancer PrognosisApr 14, 2022 · Application 17484179Pending
Methods And Materials For Assessing Allelic ImbalanceJan 18, 2022 · US 11,225,685Granted
Method Of Treating CancerNov 16, 2021 · US 11,174,519Granted
Gene Signatures For Cancer PrognosisNov 16, 2021 · US 11,174,517Granted
Methods And Materials For Assessing Homologous Recombination DeficiencyOct 7, 2021 · Application 17353279Pending
Hereditary Cancer GenesAug 31, 2021 · US 11,104,956Granted
Methods And Systems For Somatic Mutations And Uses ThereofAug 26, 2021 · Application 17313946Pending
Genes And Gene Signatures For Diagnosis And Treatment Of MelanomaJun 1, 2021 · US 11,021,752Granted
Gene Signatures For Cancer PrognosisMar 23, 2021 · US 10,954,568Granted

10X Genomics, Inc.Similar federal contract value in Biotech · $26.4M in contracts
GENVEC, INC.Similar federal contract value in Biotech · $25.3M in contracts
SANARIA INC.Similar federal contract value in Biotech · $25M in contracts
PARABON NANOLABS, INC.Similar federal contract value in Biotech · $24.7M in contracts
MICROBIOTIX, INC.Similar federal contract value in Biotech · $23.7M in contracts
Biospyder Technologies, Inc.Similar federal contract value in Biotech · $23.1M in contracts

Regulatory activity · Biotech

Sector-level, not company-level

07 Jul 2026New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
30 Jun 2026Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
30 Jun 2026Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
29 Jun 2026Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
26 Jun 2026Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
26 Jun 2026Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through Oct 23, 2026. SBIR and STTR awards through Oct 21, 2026.